PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2002Arquivos Brasileiros de Cardiologia13 citationsOpen Access

Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital

View Full Paper
LZLeonardo Antônio Mamede ZornoffSPSérgio Alberto Rupp de PaivaVAVanessa M. Assalin

Structured PICO

P
Population
172 patients with acute myocardial infarction admitted to the intensive care unit of an academic medical center hospital between January 1992 and December 1997.
O
Outcome
Predictors of 30-day mortality and adherence to international recommendations for treatmenthard clinical

This retrospective study identified key predictors of 30-day mortality in acute MI patients and highlighted the underutilization of guideline-recommended therapies in an academic medical center.

Abstract

OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We retrospectively studied 172 patients with acute myocardial infarction, admitted in the intensive care unit from January 1992 to December 1997. RESULTS: Most patients were male (68%), white (97%), and over 60 years old (59%). The main risk factor for coronary atherosclerotic disease was systemic blood hypertension (63%). Among all the variables studied, reperfusion therapy, smoking, hypertension, cardiogenic shock, and age were the predictors of 30-day mortality. Most commonly used medications were: acetylsalicylic acid (71%), nitrates (61%), diuretics (51%), angiotensin-converting enzyme inhibitors (46%), thrombolytic therapy (39%), and beta-blockers (35%). CONCLUSION: The absence of reperfusion therapy, smoking status, hypertension, cardiogenic shock, and advanced age are predictors of 30-day mortality in patients with acute myocardial infarction. In addition, some medications that are undoubtedly beneficial have been under-used after acute myocardial infarction.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zornoff et al. (2002) studied this question.

synapsesocial.com/papers/6a1def94ef3fa0b4c0ef9763https://doi.org/10.1590/s0066-782x2002000400007
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk Stratification and Survival after Myocardial Infarction1983 · 1,614 citations
  2. 2Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 19941998 · 835 citations
  3. 3Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries1995 · 115 citations
  4. 4The Open-Artery Hypothesis1998 · 96 citations
  5. 5Beta-Adrenergic Blockade in Chronic Heart Failure1998 · 30 citations